Concepedia
Statistics
Publications
6
Citations
585
H-Index
Active since
2016
Affiliations
Eli Lilly (Spain)(Current)
Eli Lilly (United States)
Lilly (China)
Carlos Marugán is an author at Eli Lilly (Spain) specializing in molecular oncology, life sciences, and pharmacology.
Publications per year
2016–2024
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong, Lacey M. Litchfield, Yue Webster et al. · Cancer Cell · 2017 · 236 citations · Full text
Life Sciences, Genetics, Molecular Biology +14
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene
Xueqian Gong, Jian Du, Stephen H. Parsons et al. · Cancer Discovery · 2018 · 233 citations
Life Sciences, Oncology, Pharmacology +17
Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
Jian Du, Lei Yan, Raquel Torres et al. · Molecular Cancer Therapeutics · 2019 · 52 citations · Full text
Medicine, Oncology, Pharmacology +15
Genetic depletion of Polo‐like kinase 1 leads to embryonic lethality due to mitotic aberrancies
Paulina Wachowicz, Gonzalo Fernández‐Miranda, Carlos Marugán et al. · BioEssays · 2016 · 26 citations · Full text
Life Sciences, Cell Biology, Genetics +16
Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple et al. · Cancer Research · 2024 · 22 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 6